Johnson & Johnson’s (NYSE:JNJ) Ethicon Endo-Surgery division finished its acquisition of Minnesota-based medical device reprocessor SterilMed Inc for an undisclosed amount.
SterilMed reprocesses medical devices and provides equipment repair and pre-owned equipment sales services. Johnson & Johnson said it plans to keep the SterilMed brand running as it integrates the business into the EES segment.
"Today we take another step forward in our strategy to provide hospitals and clinicians with a full portfolio of solutions that address pressing healthcare needs," Karen Licitra, EES’s worldwide franchise chairman said in prepared remarks.
In conjunction with the merger, SterilMed named med-tech industry veteran Mike Gustafson company president.
Gustafson, a 23-year J&J veteran, will take over for SterilMed’s outgoing chairman & CEO, Brian Sullivan, who plans to retire after a transitional period.
"I am confident Mike will prove to be an excellent leader to take SterilMed to the next level," said Sullivan in prepared remarks. "I believe SterilMed is in a strong position with a great new opportunity to work with EES to serve customers and grow our business."
Here’s a roundup of companies announcing mergers, acquisitions and divestitures.
- Siemens adds MobileMD to its arsenal
Siemens Healthcare (NYSE:SI) entered into definitive agreement to acquire health information exchange developer MobileMD Inc. for an undisclosed amount.
- Maquet Cardiovascular completes acquisition of Atrium Medical
Getinge Group subsidiary Maquet Cardiovascular completed the acquisition of of Atrium Medical Corp. Atrium will operate as an independent business unit of Maquet and will retain its current brand name.
- Alvarion buys Wavion for $26.5M
Alvarion Ltd. (NASDAQ:ALVR) bought wi-fi network solutions company Wavion for $26.5 million dollars from Tel Aviv-based Elron Electronic Industries Ltd.
- Vention Medical acquires ATEK Medical Group
Med-device outsourcing company Vention Medical signed a definitive agreement to acquire ATEK Medical Group for an undisclosed amount.
- SurModics to sell pharmaceutical assets for $30M cash
Eden Prairie, Minn.-based SurModics Inc. (NASDAQ:SRDX) entered into agreements to sell its SurModics Pharmaceuticals assets to Evonik Industries for $30M cash.
- Navigating the path to market
- Winning regulatory approval
- Corporate culture
- Entering global markets
DeviceTalks Minnesota's leadership track is designed to provide attendees with insights on topics such as:
Use code SAVE15 to save 15%!